However, when m SEPT9 with mS DC2 were combined as ColoDefense test, no significant difference was apparent in detecting CRC among different locations or tumor sizes.
← all excerpts
Aberrant DNA Methylation of <i>SEPT9</i> and <i>SDC2</i> in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection.
1
—
—